Other rare ovarian cancers: Transitional cell carcinoma, malignant Brenner tumor, endometrioid carcinoma, mesothelioma, squamous cell carcinoma, sarcoma Book Section

  


Authors: Somasegar, S.; Kertowidjojo, E.; Chui, M. H.; Ramalingam, P.; Liu, Y.; Aviki, E.
Editors: Frumovitz, M.; Leitao, M. M. Jr; Ramalingam, P.
Article/Chapter Title: Other rare ovarian cancers: Transitional cell carcinoma, malignant Brenner tumor, endometrioid carcinoma, mesothelioma, squamous cell carcinoma, sarcoma
Abstract: This chapter reviews the epidemiology, clinical presentation, diagnosis, pathology, treatment, surveillance guidelines, and treatment for recurrences for ultrarare ovarian malignancies based on the existing literature and by drawing from similar histologic subtypes from other primary tumor sites. Ovarian cancers are typically classified as epithelial cancers, which comprise 90% to 95% of all ovarian cancer cases, and nonepithelial cancers. Furthermore, among the nonepithelial cancers, there are a group of ultrarare subtypes, which include transitional cell carcinoma, endometrioid carcinoma, neuroendocrine tumors, mesothelioma, squamous cell carcinoma, and ovarian sarcomas. Scarce data exist on the diagnosis, treatment, management, surveillance, and recurrence treatment for these ultrarare subtypes of nonepithelial ovarian cancer, as most information comes from small case reports or case series. While there are some guidelines for management of these tumors, most of the current practice recommendations are extrapolated from guidelines for more common cancers with similar histology. © 2023 Elsevier Inc. All rights reserved.
Keywords: treatment; ovarian cancer; sarcoma; diagnosis; mesothelioma; transitional cell; neuroendocrine; squamous cell; endometrioid; rare
Book Title: Diagnosis and Treatment of Rare Gynecologic Cancers
ISBN: 978-0-323-82938-0
Publisher: Elsevier Inc.  
Publication Place: Amsterdam, Netherlands
Date Published: 2023-01-01
Start Page: 121
End Page: 141
Language: English
DOI: 10.1016/b978-0-323-82938-0.00008-2
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152348976&doi=10.1016%2fB978-0-323-82938-0.00008-2&partnerID=40&md5=d4f717acd1884572e48e6bab3b7bcaa6
Notes: Book Chapter: 8, part of "Section A: Ovarian cancers" -- Export Date: 1 May 2023 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Emeline Mariam Aviki
    81 Aviki
  2. Ying Liu
    105 Liu
  3. Michael Herman Chui
    60 Chui
Related MSK Work